BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25303645)

  • 1. (67/68)Ga-labeling agent that liberates (67/68)Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels.
    Uehara T; Rokugawa T; Kinoshita M; Nemoto S; Fransisco Lazaro GG; Hanaoka H; Arano Y
    Bioconjug Chem; 2014 Nov; 25(11):2038-45. PubMed ID: 25303645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Gallium-67/68-Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake.
    Uehara T; Yokoyama M; Suzuki H; Hanaoka H; Arano Y
    Clin Cancer Res; 2018 Jul; 24(14):3309-3316. PubMed ID: 29666303
    [No Abstract]   [Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels.
    Uehara T; Koike M; Nakata H; Hanaoka H; Iida Y; Hashimoto K; Akizawa H; Endo K; Arano Y
    Bioconjug Chem; 2007; 18(1):190-8. PubMed ID: 17226973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
    Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC
    J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical design of radiolabeled antibody fragments for low renal radioactivity levels.
    Arano Y; Fujioka Y; Akizawa H; Ono M; Uehara T; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Saji H
    Cancer Res; 1999 Jan; 59(1):128-34. PubMed ID: 9892197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
    Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
    J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal metabolism of 3'-iodohippuryl N(epsilon)-maleoyl-L-lysine (HML)-conjugated Fab fragments.
    Fujioka Y; Arano Y; Ono M; Uehara T; Ogawa K; Namba S; Saga T; Nakamoto Y; Mukai T; Konishi J; Saji H
    Bioconjug Chem; 2001; 12(2):178-85. PubMed ID: 11312678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios.
    Suzuki H; Kise S; Kaizuka Y; Watanabe R; Sugawa T; Furukawa T; Fujii H; Uehara T
    ACS Omega; 2021 Aug; 6(33):21556-21562. PubMed ID: 34471758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal brush border enzyme-cleavable linkages for low renal radioactivity levels of radiolabeled antibody fragments.
    Akizawa H; Imajima M; Hanaoka H; Uehara T; Satake S; Arano Y
    Bioconjug Chem; 2013 Feb; 24(2):291-9. PubMed ID: 23330714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Radiolabeled Exendin Analogues Show Reduced Renal Retention.
    Joosten L; Frielink C; Jansen TJP; Lobeek D; Andreae F; Konijnenberg M; Heskamp S; Gotthardt M; Brom M
    Mol Pharm; 2023 Jul; 20(7):3519-3528. PubMed ID: 37265006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Handling of
    Uehara T; Kanazawa N; Suzuki C; Mizuno Y; Suzuki H; Hanaoka H; Arano Y
    Bioconjug Chem; 2020 Nov; 31(11):2618-2627. PubMed ID: 33085454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
    Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
    J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ga-68-labeled neolactosylated human serum albumin (LSA) for PET imaging of hepatic asialoglycoprotein receptor.
    Choi J; Jeong JM; Yoo BC; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK
    Nucl Med Biol; 2015 Jan; 42(1):53-8. PubMed ID: 25240913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment.
    Wu C; Jagoda E; Brechbiel M; Webber KO; Pastan I; Gansow O; Eckelman WC
    Bioconjug Chem; 1997; 8(3):365-9. PubMed ID: 9177842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of 68Ga-labeled mannosylated human serum albumin (MSA) as a lymph node imaging agent for positron emission tomography.
    Choi JY; Jeong JM; Yoo BC; Kim K; Kim Y; Yang BY; Lee YS; Lee DS; Chung JK; Lee MC
    Nucl Med Biol; 2011 Apr; 38(3):371-9. PubMed ID: 21492786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [
    Zhang M; Kang F; Xing T; Wang J; Ma T; Li G; Quan Z; Yang W; Chen X; Wang J
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1713-1724. PubMed ID: 38216779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of a (67)Ga-labeled anti-TNF VHH single-domain antibody containing a bacterial albumin-binding domain (Zag).
    Morais M; Cantante C; Gano L; Santos I; Lourenço S; Santos C; Fontes C; Aires da Silva F; Gonçalves J; Correia JD
    Nucl Med Biol; 2014 May; 41 Suppl():e44-8. PubMed ID: 24530366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation.
    Zhang M; Jacobson O; Kiesewetter DO; Ma Y; Wang Z; Lang L; Tang L; Kang F; Deng H; Yang W; Niu G; Wang J; Chen X
    Bioconjug Chem; 2019 Jun; 30(6):1745-1753. PubMed ID: 31181890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.